The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Personal Genome Testing Market Research Report 2025
Synopsis
The global Personal Genome Testing market was valued at US$ 1795.8 million in 2023 and is anticipated to reach US$ 3178.8 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
North American market for Personal Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Personal Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Personal Genome Testing in Neurological Disorders is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Personal Genome Testing include 23andMe, Inc., Navigenics, deCODEme, Color Genomics, Inc., Personal Genome Diagnostics, Inc., Counsyl, Inc., Quest Diagnostics and Gene By Gene, Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personal Genome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personal Genome Testing.
Report Scope
The Personal Genome Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personal Genome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personal Genome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Segment by Type
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Segment by Application
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personal Genome Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Personal Genome Testing market was valued at US$ 1795.8 million in 2023 and is anticipated to reach US$ 3178.8 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
North American market for Personal Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Personal Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Personal Genome Testing in Neurological Disorders is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Personal Genome Testing include 23andMe, Inc., Navigenics, deCODEme, Color Genomics, Inc., Personal Genome Diagnostics, Inc., Counsyl, Inc., Quest Diagnostics and Gene By Gene, Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personal Genome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personal Genome Testing.
Report Scope
The Personal Genome Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personal Genome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personal Genome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Segment by Type
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Segment by Application
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personal Genome Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personal Genome Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted Testing
1.2.3 Non-Targeted Testing
1.2.4 Multi-Targeted Testing
1.3 Market by Application
1.3.1 Global Personal Genome Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Disorders
1.3.3 Oncology
1.3.4 Metabolic Disorders
1.3.5 Autoimmune Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personal Genome Testing Market Perspective (2019-2030)
2.2 Personal Genome Testing Growth Trends by Region
2.2.1 Global Personal Genome Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personal Genome Testing Historic Market Size by Region (2019-2024)
2.2.3 Personal Genome Testing Forecasted Market Size by Region (2025-2030)
2.3 Personal Genome Testing Market Dynamics
2.3.1 Personal Genome Testing Industry Trends
2.3.2 Personal Genome Testing Market Drivers
2.3.3 Personal Genome Testing Market Challenges
2.3.4 Personal Genome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personal Genome Testing Players by Revenue
3.1.1 Global Top Personal Genome Testing Players by Revenue (2019-2024)
3.1.2 Global Personal Genome Testing Revenue Market Share by Players (2019-2024)
3.2 Global Personal Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personal Genome Testing Revenue
3.4 Global Personal Genome Testing Market Concentration Ratio
3.4.1 Global Personal Genome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personal Genome Testing Revenue in 2023
3.5 Personal Genome Testing Key Players Head office and Area Served
3.6 Key Players Personal Genome Testing Product Solution and Service
3.7 Date of Enter into Personal Genome Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personal Genome Testing Breakdown Data by Type
4.1 Global Personal Genome Testing Historic Market Size by Type (2019-2024)
4.2 Global Personal Genome Testing Forecasted Market Size by Type (2025-2030)
5 Personal Genome Testing Breakdown Data by Application
5.1 Global Personal Genome Testing Historic Market Size by Application (2019-2024)
5.2 Global Personal Genome Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personal Genome Testing Market Size (2019-2030)
6.2 North America Personal Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Personal Genome Testing Market Size by Country (2019-2024)
6.4 North America Personal Genome Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personal Genome Testing Market Size (2019-2030)
7.2 Europe Personal Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Personal Genome Testing Market Size by Country (2019-2024)
7.4 Europe Personal Genome Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personal Genome Testing Market Size (2019-2030)
8.2 Asia-Pacific Personal Genome Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Personal Genome Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Personal Genome Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personal Genome Testing Market Size (2019-2030)
9.2 Latin America Personal Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Personal Genome Testing Market Size by Country (2019-2024)
9.4 Latin America Personal Genome Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personal Genome Testing Market Size (2019-2030)
10.2 Middle East & Africa Personal Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Personal Genome Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Personal Genome Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Detail
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Personal Genome Testing Introduction
11.1.4 23andMe, Inc. Revenue in Personal Genome Testing Business (2019-2024)
11.1.5 23andMe, Inc. Recent Development
11.2 Navigenics
11.2.1 Navigenics Company Detail
11.2.2 Navigenics Business Overview
11.2.3 Navigenics Personal Genome Testing Introduction
11.2.4 Navigenics Revenue in Personal Genome Testing Business (2019-2024)
11.2.5 Navigenics Recent Development
11.3 deCODEme
11.3.1 deCODEme Company Detail
11.3.2 deCODEme Business Overview
11.3.3 deCODEme Personal Genome Testing Introduction
11.3.4 deCODEme Revenue in Personal Genome Testing Business (2019-2024)
11.3.5 deCODEme Recent Development
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Detail
11.4.2 Color Genomics, Inc. Business Overview
11.4.3 Color Genomics, Inc. Personal Genome Testing Introduction
11.4.4 Color Genomics, Inc. Revenue in Personal Genome Testing Business (2019-2024)
11.4.5 Color Genomics, Inc. Recent Development
11.5 Personal Genome Diagnostics, Inc.
11.5.1 Personal Genome Diagnostics, Inc. Company Detail
11.5.2 Personal Genome Diagnostics, Inc. Business Overview
11.5.3 Personal Genome Diagnostics, Inc. Personal Genome Testing Introduction
11.5.4 Personal Genome Diagnostics, Inc. Revenue in Personal Genome Testing Business (2019-2024)
11.5.5 Personal Genome Diagnostics, Inc. Recent Development
11.6 Counsyl, Inc.
11.6.1 Counsyl, Inc. Company Detail
11.6.2 Counsyl, Inc. Business Overview
11.6.3 Counsyl, Inc. Personal Genome Testing Introduction
11.6.4 Counsyl, Inc. Revenue in Personal Genome Testing Business (2019-2024)
11.6.5 Counsyl, Inc. Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Personal Genome Testing Introduction
11.7.4 Quest Diagnostics Revenue in Personal Genome Testing Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
11.8 Gene By Gene, Ltd.
11.8.1 Gene By Gene, Ltd. Company Detail
11.8.2 Gene By Gene, Ltd. Business Overview
11.8.3 Gene By Gene, Ltd. Personal Genome Testing Introduction
11.8.4 Gene By Gene, Ltd. Revenue in Personal Genome Testing Business (2019-2024)
11.8.5 Gene By Gene, Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
